Initiate patient dosing for the UPLIFT clinical trial
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- April 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Planning to Initiate UPLIFT Patient Dosing in Q1 2021”
What we found
Evidence strength A What the grades mean
The company announced in May 2021 that it initiated patient dosing for the UPLIFT trial in April 2021, which is after the Q1 2021 deadline.
-
A Mersana Therapeutics, Inc. 8-K filed 2021-05-10
“In April 2021, the Company announced the initiation of patient dosing in UPLIFT” ✓ confirmed on the page
-
A Mersana Therapeutics, Inc. 10-Q filed 2021-05-10
“In April 2021, we initiated a single-arm registration strategy in platinum-resistant ovarian cancer, UPLIFT” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- UPLIFT patient dosing
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Mersana Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C442836-021026 · Corrections policy